Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124227554 | 12422755 | 4 | F | 20151019 | 20160923 | 20160601 | 20160930 | EXP | PHHY2016TW073167 | NOVARTIS | 37.00 | YR | M | Y | 77.00000 | KG | 20160930 | MD | TW | TW |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124227554 | 12422755 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 600 MG, BID | 160800 | MG | N | 22068 | 600 | MG | CAPSULE | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124227554 | 12422755 | 1 | Chronic myeloid leukaemia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124227554 | 12422755 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124227554 | 12422755 | Anaemia | |
124227554 | 12422755 | Mucosal inflammation | |
124227554 | 12422755 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124227554 | 12422755 | 1 | 20150914 | 20160320 | 0 |